These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 20133005)
41. Letter to the Editor: Is eliminating METTL1-mediated accumulation of PMN-MDSCs sufficient to prevent hepatocellular carcinoma recurrence after radiofrequency ablation? Yang F; Jiang S; Zheng Y Hepatology; 2023 Apr; 77(4):E62-E63. PubMed ID: 35753066 [No Abstract] [Full Text] [Related]
42. Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat. Kurokohchi K; Watanabe S; Masaki T; Hosomi N; Funaki T; Arima K; Yoshida S; Nakai S; Murota M; Miyauchi Y; Kuriyama S Int J Oncol; 2002 Sep; 21(3):611-5. PubMed ID: 12168107 [TBL] [Abstract][Full Text] [Related]
43. Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis: a retrospective study of efficacy and cost. Seror O; N'Kontchou G; Tin Tin Htar M; Durand-Zaleski I; Trinchet JC; Sellier N; Beaugrand M Gastroenterol Clin Biol; 2006 Nov; 30(11):1265-73. PubMed ID: 17185968 [TBL] [Abstract][Full Text] [Related]
44. Percutaneous ethanol injection of unresectable medium-to-large-sized hepatomas using a multipronged needle: efficacy and safety. Ho CS; Kachura JR; Gallinger S; Grant D; Greig P; McGilvray I; Knox J; Sherman M; Wong F; Wong D Cardiovasc Intervent Radiol; 2007; 30(2):241-7. PubMed ID: 17200905 [TBL] [Abstract][Full Text] [Related]
45. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation. Castroagudin JF; Delgado M; Martinez SM; Abdulkader I; Potel J; Tome S; Otero E; Varo E Transplant Proc; 2005 Apr; 37(3):1477-9. PubMed ID: 15866645 [TBL] [Abstract][Full Text] [Related]
46. Endoscopic ultrasonography-guided ethanol injection as a treatment for ruptured hepatocellular carcinoma in the left hepatic lobe. Nakaji S; Hirata N; Kobayashi M; Shiratori T; Sanagawa M Endoscopy; 2015; 47 Suppl 1():E558-60. PubMed ID: 26610083 [No Abstract] [Full Text] [Related]
48. [Evaluation of efficacy of liver cancer microwave ablation at 5 years postoperatively]. Zhao L; Zhuang DM; Hou XW; Wang GF; Zhang HW; Zhuang XX Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):648-650. PubMed ID: 31594085 [TBL] [Abstract][Full Text] [Related]
49. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Ohnishi K; Yoshioka H; Ito S; Fujiwara K Hepatology; 1998 Jan; 27(1):67-72. PubMed ID: 9425919 [TBL] [Abstract][Full Text] [Related]
59. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria. Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028 [TBL] [Abstract][Full Text] [Related]
60. Transpulmonary radiofrequency ablation of hepatocellular carcinoma contiguous to the heart. Iguchi T; Inoue D; Tatsukawa M; Yabushita K; Sakaguchi K; Kanazawa S Diagn Interv Imaging; 2015 Nov; 96(11):1207-9. PubMed ID: 26277644 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]